Ad
related to: pharmaceutical packaging requirements
Search results
Results from the WOW.Com Content Network
Example pharmaceutical packaging line. All aspects of pharmaceutical production, including packaging, are tightly controlled and have regulatory requirements. Uniformity, cleanliness , sterility, and other requirements are needed to maintain Good Manufacturing Practices. Product safety management is vital.
Blister packs are commonly used as unit-dose packaging for pharmaceutical tablets, capsules or lozenges. Blister packs can provide barrier protection for shelf life requirements, and a degree of tamper resistance. In the US, blister packs are mainly used for packing physician samples of drug products or for over-the-counter (OTC) products in ...
Packaging testing might have a variety of purposes, such as: Determine if, or verify that, the requirements of a specification, regulation, or contract are met; Decide if a new product development program is on track: Demonstrate proof of concept; Provide standard data for other scientific, engineering, and quality assurance functions
Packaging may be described in relation to the type of product being packaged: medical device packaging, bulk chemical packaging, over-the-counter drug packaging, retail food packaging, military materiel packaging, pharmaceutical packaging, etc. It is sometimes convenient to categorize packages by layer or function: primary, secondary, tertiary,etc.
Current good manufacturing practices (cGMP) are those conforming to the guidelines recommended by relevant agencies.Those agencies control the authorization and licensing of the manufacture and sale of food and beverages, [1] cosmetics, [2] pharmaceutical products, [3] dietary supplements, [4] and medical devices. [5]
By the late 1980s, BFS had been well-established in the packaging industry, especially for packaging pharmaceutical and healthcare products. [14] During the 1980s and 1990s, BFS came into use for the now common small volume unit-dosage forms. [12] Since the early 2000s, BFS has been emerging as the preferred packaging process for parenteral ...
The child-resistant locking closure for containers was invented in 1967 by Dr. Henri Breault. [7]A history of accidents involving children opening household packaging and ingesting the contents led the United States Congress to pass the Poison Prevention Packaging Act of 1970, authored by U.S. Senator Frank E. Moss of Utah.
The 2009 Brazilian Federal Law 11.903 and subsequent regulations of the National Agency for Sanitary Surveillance in Brazil (ANVISA) require that a 2D data matrix code be put on all secondary packaging. Under these provisions, manufacturers will be required to maintain a database of all transactions from manufacturing to dispensing, while ...
Ad
related to: pharmaceutical packaging requirements